How inflammation from obesity affects heart rhythm channels
Channelopathies of Inflammation
['FUNDING_R01'] · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · NIH-11258042
Testing whether blocking the inflammatory signal IL-6 can prevent dangerous heart rhythm changes linked to obesity.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH (nih funded) |
| Locations | 1 site (SALT LAKE CITY, UNITED STATES) |
| Trial ID | NIH-11258042 on ClinicalTrials.gov |
What this research studies
If I have obesity-related inflammation, this work looks at how that inflammation changes the electrical channels in heart cells that control heartbeat. Researchers will study cells in the lab to see how IL-6 signaling alters potassium and calcium handling in heart cells. They will also use a high-fat diet guinea pig model to see whether an IL-6 blocker can reduce irregular and dangerous heart rhythms in a living system. The goal is to link the lab findings to a possible treatment approach that could later be tested in people.
Who could benefit from this research
Good fit: Ideal candidates for future clinical testing would be adults with obesity who have evidence of chronic inflammation and either prolonged QT or a history or high risk of ventricular arrhythmias.
Not a fit: People whose arrhythmias are caused by non-inflammatory factors (for example congenital channelopathies unrelated to inflammation or structural heart disease) may not benefit from IL-6–targeted approaches.
Why it matters
Potential benefit: If successful, this could point to new IL-6–targeting treatments that lower the risk of life-threatening ventricular arrhythmias in people with obesity-related inflammation.
How similar studies have performed: Anti-IL-6 agents such as olamkicept have shown promise in inflammatory bowel disease, but applying IL-6 blockade specifically to prevent ventricular tachyarrhythmias is largely novel and unproven.
Where this research is happening
SALT LAKE CITY, UNITED STATES
- UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH — SALT LAKE CITY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: AROMOLARAN, ADEMUYIWA — UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH
- Study coordinator: AROMOLARAN, ADEMUYIWA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.